1. CTNI-50. A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB/OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: UPDATED RESULTS. (14th November 2022) Authors: Hsieh, Annie; Gerstner, Elizabeth; Sahebjam, Solmaz; Piccioni, David; Campian, Jian; Drappatz, Jan; Aiken, Robert; Lee, Eudocia; Welch, Mary; Becker, Kevin; Williams, Mickey; Karlovich, Christopher; Muzikansky, Alona; Giglio, Pierre; Ivy, Percy; Batchelor, Tracy; Arrillaga-Romany, Isabel Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗